Lite Strategy Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lite Strategy Inc
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Lite Strategy Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lite Strategy Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lite Strategy Inc is LITS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lite Strategy Inc has its primary listing on NASDAQ (Small cap). You can trade Lite Strategy Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lite Strategy Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lite Strategy Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lite Strategy Inc .